Aditxt, Inc. Number of Operating Segments
Aditxt, Inc. (ADTX) reported Number of Operating Segments of 1 Segment for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfOperatingSegments · last filed 2026-05-20
- 2025-09-30: Number of Operating Segments 9 month 100.00%.
- 2025-06-30: Number of Operating Segments 6 month 100.00%.
pure
| Period end | Number of Operating Segments 6 month | Number of Operating Segments 9 month |
|---|---|---|
| 2025-09-30 | 100.00% 10-Q · filed 2025-11-18 | |
| 2025-06-30 | 100.00% 10-Q · filed 2025-08-14 |
Segment
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 12 month |
|---|---|---|
| 2026-03-31 | 1.00 Segment 10-Q · filed 2026-05-20 | |
| 2025-12-31 | 1.00 Segment 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |